Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 361
Filtrar
1.
Vestn Otorinolaringol ; 89(2): 66-70, 2024.
Artículo en Ruso | MEDLINE | ID: mdl-38805466

RESUMEN

The literature review presents current data on the epidemiology, drug, and surgical treatment of laryngeal papillomatosis in adults. Possible prospects for further study of the prevalence and incidence of the disease and provoking factors of recurrence of the disease for the development of possible preventive measures are considered.


Asunto(s)
Neoplasias Laríngeas , Papiloma , Humanos , Neoplasias Laríngeas/epidemiología , Neoplasias Laríngeas/cirugía , Neoplasias Laríngeas/diagnóstico , Papiloma/epidemiología , Papiloma/cirugía , Papiloma/diagnóstico , Adulto , Prevalencia , Incidencia , Laringe/cirugía , Laringe/patología
2.
Rev. ADM ; 81(1): 61-66, ene.-feb. 2024. ilus, tab
Artículo en Español | LILACS | ID: biblio-1560711

RESUMEN

En 1871, el cirujano Johann von Mikulicz Radecki, de la Universidad de Viena en Austria, introdujo por primera vez la descripción del papiloma escamoso; finalmente en 2002, se reclasificó como una familia independiente con un total de 29 genes, de los cuales cinco se asocian al papiloma humano. En 2021, el Centro Internacional de Referencia del Virus del Papiloma Humano del Instituto Karolinska reportó un total de 228 diferentes tipos de VPH (AU)


In 1871, the surgeon Johann von Mikulicz Radecki, from the University of Vienna in Austria, first introduced the description of squamous papilloma; finally, in 2002, it was reclassified as an independent family with a total of 29 genes, of which five are associated. to human papilloma. In 2021, the International Reference Center for Human Papillomavirus at the Karolinska Institute reported a total of 228 different types of HPV (AU)


Asunto(s)
Humanos , Masculino , Adulto , Papiloma/diagnóstico , Papillomaviridae/clasificación , Papiloma/cirugía , Papiloma/patología , Papiloma/epidemiología , Crioterapia/métodos , Diagnóstico Diferencial
3.
Comp Immunol Microbiol Infect Dis ; 104: 102111, 2024 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-38101193

RESUMEN

Papillomaviruses can cause benign or malignant proliferations on the host's skin and mucous membranes. Recent genetic studies have identified many new papillomavirus types. In this study, molecular detection and typing was performed on papilloma samples from eight hair goats with teat papillomatosis. The papilloma samples were tested with degenerate (FAP59/FAP64,MY09/MY11) and type-specific primers. One sample was positive with degenerate (MY09/MY11) and two samples were positive with Caprahircus papillomavirus-1 type specific primers. The MY09/MY11 primer sequence indicated identity to the closest Ovine papillomavirus type-2 (77.9%). The ChPV-1 primer sequence was similar to the closest ChPV-1 (99.4%). Investigating papillomavirus types in different animal species is important for determining the evolution, prevalence, host range, and interspecies transmission potential of papillomaviruses, and to indicate suitable therapeutics for later development.


Asunto(s)
Enfermedades de las Cabras , Papiloma , Enfermedades de las Ovejas , Virosis , Animales , Ovinos , Cabras , Turquía , Papiloma/veterinaria , Papiloma/epidemiología , Virosis/veterinaria , Papillomaviridae/genética , Genotipo , ADN Viral/genética , Enfermedades de las Cabras/epidemiología
4.
Orphanet J Rare Dis ; 18(1): 99, 2023 04 29.
Artículo en Inglés | MEDLINE | ID: mdl-37120568

RESUMEN

If esophageal papilloma (EP) is a rare condition, esophageal papillomatosis (EPS) is a distinct rarity. To date, only 53 well documented cases have been described in English literature. However, the number of reports on EPS significantly increased to over 40 cases during the past 20 years. Perhaps, this is due to the broad use of endoscopy and related research achievements. Most of the cases are individual and it seems that there are no associations between them. And up to now no guidelines can be followed. To further understand this exceedingly rare disease, we had a comprehensive review of the epidemiology, etiology, clinical manifestations, pathogenesis, treatment, and clinical course of EPS.


Asunto(s)
Neoplasias Esofágicas , Papiloma , Humanos , Enfermedades Raras/complicaciones , Neoplasias Esofágicas/diagnóstico , Neoplasias Esofágicas/epidemiología , Neoplasias Esofágicas/etiología , Papiloma/diagnóstico , Papiloma/epidemiología , Papiloma/complicaciones , Endoscopía
5.
Dis Aquat Organ ; 149: 133-143, 2022 Jun 23.
Artículo en Inglés | MEDLINE | ID: mdl-35735233

RESUMEN

Fibropapillomatosis (FP) is a tumor disease that affects all sea turtle species but is mainly seen in green turtles Chelonia mydas. The pathology of FP has been described extensively, but its dynamics in populations over time have been less studied. We analyzed the dynamics of FP in a population of green turtles in Akumal Bay on the central coast of the Mexican Caribbean. A total of 475 green turtles were captured over 15 yr (2004-2018). The highest prevalence of FP was found in the largest turtles, and there was a positive relationship between FP prevalence and size of turtles. FP was first detected in 2008 at a prevalence of 1.6%, and annual prevalence increased markedly from 17.9% in 2015 to 54% by 2018. Likewise, severity of FP increased over time, with most turtles falling into moderately to severely diseased categories (tumor score 2). The average size of turtles with FP was significantly larger than the size of individuals without FP. Regression of tumors was seen in 21% of turtles, tumor score was higher in smaller individuals, and only tumor score 2 was present in the largest sea turtles. An increase in the prevalence and tumor score of FP coincided with the massive arrival of Sargassum in 2015, suggesting that altered environmental conditions may have played a role. The increased prevalence of FP in Akumal Bay prompts the need to explain what might be driving this phenomenon and how widespread it is in the Caribbean.


Asunto(s)
Papiloma , Neoplasias Cutáneas , Tortugas , Animales , Bahías , México/epidemiología , Papiloma/epidemiología , Papiloma/veterinaria , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/veterinaria
6.
Pediatr Dermatol ; 38(5): 1202-1209, 2021 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-34561886

RESUMEN

BACKGROUND/OBJECTIVES: Confluent and reticulated papillomatosis is a skin condition with unclear etiology and limited understanding of risk factors, comorbidities, and treatment strategies in the pediatric population. This study aims to describe the varied presentations and outcomes of confluent and reticulated papillomatosis and report associated comorbidities in pediatric patients. METHODS: In this retrospective single-institution case-control study, pediatric patients with a diagnosis of confluent and reticulated papillomatosis seen between 2012 and 2020 were matched approximately 1:5 with an acne vulgaris cohort based on diagnosis, setting, and time period when seen. The primary measures were the clinical features, demographics, comorbidities, treatment, and outcomes of patients with confluent and reticulated papillomatosis. Univariate and multivariable analyses were conducted to describe the association of confluent and reticulated papillomatosis with several potential risk factors and comorbidities. RESULTS: Patients with confluent and reticulated papillomatosis typically presented in adolescence with a median age of 14 years and female predominance. In a multivariable analysis, patients with confluent and reticulated papillomatosis were significantly more likely to identify as Black, be overweight or obese, and have concurrent acanthosis nigricans compared to control patients. Most of the confluent and reticulated papillomatosis patients were treated with oral minocycline or doxycycline. Although all patients who received antibiotics responded to treatment, approximately half presented with recurrence, typically within 1-2 years of first treatment. CONCLUSIONS: Confluent and reticulated papillomatosis is a disorder that presents in adolescence and appears to be more frequent in patients who are Black, obese, or overweight, and also have acanthosis nigricans. Clinicians should assess patients with confluent and reticulated papillomatosis for comorbidities, particularly those associated with insulin resistance, which may help reduce long-term disease burden.


Asunto(s)
Papiloma , Neoplasias Cutáneas , Adolescente , Estudios de Casos y Controles , Niño , Femenino , Humanos , Recurrencia Local de Neoplasia , Papiloma/diagnóstico , Papiloma/tratamiento farmacológico , Papiloma/epidemiología , Estudios Retrospectivos , Neoplasias Cutáneas/diagnóstico , Neoplasias Cutáneas/tratamiento farmacológico , Neoplasias Cutáneas/epidemiología
7.
J Pediatr Gastroenterol Nutr ; 72(5): 690-692, 2021 05 01.
Artículo en Inglés | MEDLINE | ID: mdl-33847287

RESUMEN

OBJECTIVES: Esophageal squamous papilloma (ESP) is a rare epithelial lesion most commonly seen in adults, with an unclear etiology and limited pediatric data available. The aim of this study was to provide an estimated prevalence of this lesion in our pediatric population, as well as to identify any demographic, clinical, or pathologic associations-including human papilloma virus (HPV) infection, which has been linked with ESP in adult literature. METHODS: ESP cases at University Hospitals Rainbow Babies & Children's Hospital were identified by conducting a retrospective search through all esophagogastroduodenoscopies (EGDs) performed in children under 18 years old, from January 1, 2000 to December 31, 2014. Histopathology reports were analyzed including Fluorescence In Situ Hybridization (FISH) for HPV, and a comprehensive chart review was performed for demographic data. RESULTS: Of 12,459 children who required an EGD, 10 children were identified with ESP on biopsy, with ages ranging from 2 to 17 years. This provides an estimated prevalence of 0.08% over the entire study period. Seventy percentage of patients underwent endoscopy for abdominal pain, and 40% presented with gastroesophageal reflux. Sixty percentage of lesions were in the proximal esophagus, and 80% of patients had isolated lesions. Notably, none of the lesions tested were positive for HPV on FISH analysis. CONCLUSIONS: ESP is a rare benign lesion found incidentally in the pediatric population. The prevalence at our institution was 0.08%. All samples tested for HPV via FISH analysis were negative. As a result, regular analysis for HPV may not be necessary in pediatric patients with ESP in the future.


Asunto(s)
Carcinoma de Células Escamosas , Neoplasias Esofágicas , Papiloma , Adolescente , Adulto , Niño , Preescolar , ADN Viral , Humanos , Hibridación Fluorescente in Situ , Papiloma/diagnóstico , Papiloma/epidemiología , Estudios Retrospectivos
8.
Rev. guatemalteca cir ; 27(1): 20-28, 2021. tab
Artículo en Español | LILACS, LIGCSA | ID: biblio-1400733

RESUMEN

La papilomatosis laríngea es la neoplasia laríngea benigna más común y está causada por el virus de papiloma humano. Se considera que la papilomatosis laríngea tiene un papel independiente como factor de riesgo de cáncer; se clasifica dentro de tres grupos de acuerdo con sus características clínicas: juvenil, adulto y recurrente. Su incidencia asociada a neoplasia maligna es del 4%. Objetivos: Determinar si existen factores de riesgo asociados al tipo de papilomatosis laríngea; y si existe relación con el tipo de papilomatosis y neoplasias asociadas. Metodología: Estudio observacional descriptivo de pacientes que acuden al servicio de Otorrinolaringología del Hospital General San juan de Dios y su caracterización. Resultados: De los 33 pacientes evaluados con papilomatosis laríngea, 51 % fueron del género masculino, la edad promedio sin incluir pacientes pediátricos fue de 23 años. La mediana de reintervenciones es de 4 veces, y la mayoría tiene pérdida del seguimiento. La papilomatosis tipo infantil es la más común con pacientes de 7 a 14 años de edad. Los pacientes con papilomatosis adulta presentaron más factores de riesgo que los pacientes con papilomatosis infantil y recurrente, p=0.01. Los pacientes presentan ronquera, disfonía y dificultad respiratoria. El diagnóstico se realiza por clínica con laringoscopía sin biopsia en la mitad de los pacientes. El 9% de los pacientes estudiados presentaron neoplasia asociada. El número de reintervenciones está asociado a un mayor riesgo de progresión a neoplasia. Conclusión: Los pacientes con papilomatosis adulta presentaron más factores de riesgo que los pacientes con papilomatosis infantil, y el 9% de los pacientes presentan una neoplasia asociada, más alta de la reportada en la literatura.(AU)


Laryngeal papillomatosis is the most common benign neoplasm and is caused by the human papilloma virus. Laryngeal papillomatosis is considered to have an independent role as risk factor. Laryngeal papillomas are classified into three groups, according to their clinical characteristics: juvenile, adult and recurrent. 4% is associated with neoplasia. Objectives: Determine if there are risk factors associated with the type of laryngeal papillomatosis and if there is a relationship with the type of papillomatosis and associated neoplasms. Methodology: Descriptive observational study of patients attending the Otolaryngology service of the General Hospital San Juan de Dios de Guatemala and their characterization. Results: Of the 33 patients evaluated with laryngeal papillomatosis, 51% were male, with an average age of 23 years. The median number of reoperations is 4, and most do not return to follow-up. Infantile type papillomatosis is the most common, with patients 7 to 14 years of age. Patients with adult papillomatosis had more risk factors than patients with infantile and recurrent papillomatosis, p= 0.01. Patients present hoarseness, dysphonia and respiratory distress upon admission. Diagnosis is made clinically with laryngoscopy without biopsy in half of the patients. 9% of the patients studied had associated neoplasia. The number of reoperations is associated with an increased risk of developing a neoplasm. Conclusion: Patients with adult papillomatosis presented more risk factors than patients with infantile papillomatosis. And 9% of the patients present associated neoplasia, higher than reported in the literature


Asunto(s)
Humanos , Femenino , Adulto , Papiloma/epidemiología , Neoplasias Laríngeas/etiología , Infecciones por Papillomavirus/diagnóstico , Neoplasias/diagnóstico , Papiloma/diagnóstico , Neoplasias Laríngeas/diagnóstico , Infecciones por Papillomavirus/tratamiento farmacológico , Laringe/patología
9.
Rev Assoc Med Bras (1992) ; 66(9): 1247-1251, 2020 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-33027453

RESUMEN

BACKGROUND: Recurrent laryngeal papillomatosis, caused by the Human Papilloma Virus, has a significant economic impact worldwide and there are no epidemiological data of this disease in Brasil. OBJECTIVE: The objective of the study was to estimate the incidence and prevalence of laryngeal papillomatosis of some otorhinolaryngology centers in São Paulo State (Brasil). METHODS: A questionnaire containing data on the number of new and follow-up cases diagnosed with laryngeal papillomatosis was sent to the Otorhinolaryngology services (n=35) of São Paulo State (Brasil). RESULTS: A total of 20 otorhinolaryngology centers answered the questionnaire. Of these, the five largest regional health centers were selected as follows: Campinas (42 cities - 4,536,657 inhabitants), Sao Jose do Rio Preto (102 cities - 1,602,845 inhabitants), Ribeirão Preto (26 cities - 1,483,715 inhabitants), Bauru (68 cities - 1,770,427 inhabitants), and Sorocaba (47 cities - 2,478,208 inhabitants). The incidence and prevalence of each regional health centers were, respectively: Campinas (5.51;7.27), Sorocaba (2.02;6.86), São José do Rio Preto (1.87;7.49), Ribeirão Preto (11.46;22.92), and Bauru (3.95;7.91). CONCLUSION: The incidence and prevalence of the laryngeal papillomatosis of the five largest regional health centers of the interior of São Paulo State (Brasil) varied between 1.87 to 11.46 and 6.86 to 22.92 per 1,000,000 inhabitants, respectively for a total population of 11,871,852 inhabitants.


Asunto(s)
Neoplasias Laríngeas , Papiloma , Brasil/epidemiología , Ciudades , Humanos , Incidencia , Neoplasias Laríngeas/epidemiología , Papiloma/epidemiología , Prevalencia
10.
Rev. Assoc. Med. Bras. (1992) ; 66(9): 1247-1251, Sept. 2020. tab, graf
Artículo en Inglés | SES-SP, LILACS | ID: biblio-1136352

RESUMEN

SUMMARY BACKGROUND: Recurrent laryngeal papillomatosis, caused by the Human Papilloma Virus, has a significant economic impact worldwide and there are no epidemiological data of this disease in Brasil. OBJECTIVE: The objective of the study was to estimate the incidence and prevalence of laryngeal papillomatosis of some otorhinolaryngology centers in São Paulo State (Brasil). METHODS: A questionnaire containing data on the number of new and follow-up cases diagnosed with laryngeal papillomatosis was sent to the Otorhinolaryngology services (n=35) of São Paulo State (Brasil). RESULTS: A total of 20 otorhinolaryngology centers answered the questionnaire. Of these, the five largest regional health centers were selected as follows: Campinas (42 cities - 4,536,657 inhabitants), Sao Jose do Rio Preto (102 cities - 1,602,845 inhabitants), Ribeirão Preto (26 cities - 1,483,715 inhabitants), Bauru (68 cities - 1,770,427 inhabitants), and Sorocaba (47 cities - 2,478,208 inhabitants). The incidence and prevalence of each regional health centers were, respectively: Campinas (5.51;7.27), Sorocaba (2.02;6.86), São José do Rio Preto (1.87;7.49), Ribeirão Preto (11.46;22.92), and Bauru (3.95;7.91). CONCLUSION: The incidence and prevalence of the laryngeal papillomatosis of the five largest regional health centers of the interior of São Paulo State (Brasil) varied between 1.87 to 11.46 and 6.86 to 22.92 per 1,000,000 inhabitants, respectively for a total population of 11,871,852 inhabitants.


RESUMO CONTEXTO: A papilomatose recorrente da laringe, causada pelo vírus do papiloma humano, tem um impacto econômico significativo em todo o mundo e não existem dados epidemiológicos dessa doença no Brasil. OBJETIVO: O objetivo do estudo foi estimar a incidência e prevalência de papilomatose laríngea em alguns centros de otorrinolaringologia do estado de São Paulo (Brasil). MÉTODOS: Um questionário contendo dados sobre o número de casos novos e de retornos diagnosticados com papilomatose laríngea foi enviado aos serviços de otorrinolaringologia (n-35) do estado de São Paulo (Brasil). RESULTADOS: Vinte centros de otorrinolaringologia responderam ao questionário e, destes, os cinco maiores centros regionais de saúde foram selecionados da seguinte forma: Campinas (42 cidades - 4.536.657 habitantes), São José do Rio Preto (102 cidades - 1.602.845 habitantes), Ribeirão Preto (26 cidades - 1.483.715 habitantes), Bauru (68 cidades - 1.770.427 habitantes) e Sorocaba (47 cidades - 2.478.208 habitantes). A incidência e prevalência de cada centro de saúde regional foram, respectivamente: Campinas (5,51; 7,27), Sorocaba (2,02; 6,86), São José do Rio Preto (1,87; 7,49), Ribeirão Preto (11,46; 22,92), Bauru (3,95; 7,91). CONCLUSÃO: A incidência e prevalência da papilomatose laríngea dos cinco mais importantes centros regionais de saúde do interior do estado de São Paulo (Brasil) variaram entre 1,87 e 11,46 e 6,86 e 22,92, por 1.000.000 de habitantes, respectivamente, para uma população total de 11.871.852 habitantes.


Asunto(s)
Humanos , Papiloma/epidemiología , Neoplasias Laríngeas/epidemiología , Brasil/epidemiología , Incidencia , Prevalencia , Ciudades
11.
Arq. bras. med. vet. zootec. (Online) ; 72(3): 926-930, May-June, 2020. ilus, tab, graf
Artículo en Inglés | LILACS, VETINDEX | ID: biblio-1129601

RESUMEN

Papillomatosis is one of the few diseases in which autovaccine therapy is recommended, especially in the case of mass manifestation in animals. It is noted that papillomas are diagnosed in 15.7% of cases in histological diagnosis of oncological diseases. Therefore, this work studied the profile of oncological diseases in dogs and the clinical effectiveness of autovaccine therapy of papillomatosis. The article gives a morphological description of papillomas used as a biomaterial, and also describes the technological methods of manufacturing an autovaccine used to treat animals against papillomatosis. A therapeutic scheme for administering the vaccine was proposed and tested, and the results of the clinical trial are presented, as well as a reflection on some moments of the mechanism of vaccine therapy for papillomatosis.(AU)


A papilomatose é uma das poucas doenças onde se recomenda a terapia com autovacina, principalmente no caso de manifestação em massa em animais. Nota-se que papilomas são diagnosticados em 15,7% dos casos em diagnóstico histológico de doenças oncológicas. Portanto, este trabalho estudou o perfil das doenças oncológicas em cães e a eficácia clínica da terapia com autovacina em papilomatose. O presente artigo fornece descrição morfológica dos papilomas utilizados como biomaterial, além da descrição dos métodos tecnológicos de fabricação de uma autovacina usada para tratar animais contra a papilomatose. Um esquema terapêutico para a administração da vacina foi proposto e testado, e os resultados do ensaio clínico são apresentados, e é feita uma reflexão sobre alguns momentos do mecanismo da terapia de vacina para papilomatose.(AU)


Asunto(s)
Animales , Perros , Papiloma/veterinaria , Papiloma/epidemiología , Células Epiteliales/patología , Autovacunas/uso terapéutico , Inmunoterapia/veterinaria
12.
Mol Genet Genomics ; 295(3): 675-684, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-32002629

RESUMEN

Laryngeal papillomas (LP) is a difficult disease to manage due to its frequent recurrence, airway compromise, and risk of cancer. Recently, growing evidence indicates the aberrant expression of OGFPD1, a stress granule protein, links closely to the development of tumorigenesis; however, little is known about its role in LP progression. Here, we investigated the tumor promoting action of OGFOD1 in LP. The transcriptional and translational levels of OGFOD1 were significantly up-regulated in LP tissues and cells. Moreover, OGFOD1 promoted viability and proliferation, and inhibited LP cells apoptosis. We further revealed that OGFOD1 was directly targeted by miR-1224-5p, which was significantly down-regulated in LP. Overexpression of the miR-1224-5p suppressed OGFOD1-induced cell proliferation and viability, and promoted apoptosis of LP. In accordance, knockdown of miR-1224-5p inversed the inhibitory effects. In confederation of the central involvement of OGFOD1 in LP progression, targeting the miR-1224-5p/OGFOD1 pathway might provide a novel strategy for LP treatment.


Asunto(s)
Proteínas Portadoras/metabolismo , Proliferación Celular , Neoplasias Laríngeas/patología , MicroARNs/genética , Proteínas Nucleares/metabolismo , Papiloma/patología , Papillomaviridae/aislamiento & purificación , Infecciones por Papillomavirus/complicaciones , Apoptosis , Proteínas Portadoras/genética , China/epidemiología , Regulación Neoplásica de la Expresión Génica , Humanos , Incidencia , Neoplasias Laríngeas/epidemiología , Neoplasias Laríngeas/virología , Proteínas Nucleares/genética , Papiloma/epidemiología , Papiloma/virología , Infecciones por Papillomavirus/virología , Células Tumorales Cultivadas
13.
J Vet Diagn Invest ; 32(1): 25-35, 2020 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-31845622

RESUMEN

We assessed the health status and hematologic and blood chemistry values of 48 juvenile green turtles (Chelonia mydas) on the southeastern coast of Brazil (25°S 48°W). We investigated the impact of size and weight, nutritional condition, and presence of epibionts and fibropapilloma tumors. Nutritional status was good for 39 animals; these animals had higher serum albumin, cholesterol, and phosphorus concentrations than 9 animals with a fair nutritional score. Reference values for hematology and biochemistry were calculated for 39 individuals without fibropapillomas (FPs). Turtles with epibionts (n = 33) had lower hemoglobin (Hb) than turtles without epibionts (n = 15; t = -2.09, p = 0.04), and the area occupied by epibionts was positively correlated with the white blood cell count (r = 0.37, p = 0.03). FP turtles had significantly lower hematocrit (Hct), Hb, and red blood cell (RBC) counts than non-FP turtles; serum albumin and cholesterol were higher in non-FP than FP turtles. A negative correlation between curved carapace length (CCL) and Hct (r = -0.51, p = 0.0002) and RBC (r = -0.47, p = 0.0007), and between serum cholesterol, sodium, and uric acid and CCL (r = -0.53, p = 0.0001; r = -0.38, p = 0.007; r = -0.35, p = 0.014, respectively) were identified. The health of turtles appears to deteriorate as they get larger, which manifests in more FPs, decreased body condition, and systemic physiologic changes consistent with chronic disease including lower Hct, RBC counts, serum cholesterol, sodium, and uric acid.


Asunto(s)
Infestaciones Ectoparasitarias/veterinaria , Papiloma/veterinaria , Tortugas/sangre , Animales , Brasil/epidemiología , Infestaciones Ectoparasitarias/sangre , Infestaciones Ectoparasitarias/patología , Estado Nutricional , Papiloma/epidemiología , Papiloma/patología , Papiloma/virología
14.
J Vet Med Sci ; 81(7): 1063-1066, 2019 Jul 19.
Artículo en Inglés | MEDLINE | ID: mdl-31130584

RESUMEN

Teat papillomatosis is one important infectious disease affecting cattle health and results in significant economic losses especially in the dairy industry. Although there is a large number of commercial cattle herds in China, limited information is available for molecular epidemiological investigation of bovine papillomaviruses (BPVs). In October 2017, an outbreak of teat papillomatosis occurred in the Shandong Province of China. Samples were collected and diagnosed with PCR, and 3 full-length viral genomes were amplified from tissue samples collected from 3 outbreak farms. Analysis results revealed that the outbreak was associated with BPV type 10. This is the first report of BPV-10 infection in China and will contribute to the molecular epidemiological study of the disease.


Asunto(s)
Enfermedades de los Bovinos/epidemiología , Enfermedades de los Bovinos/virología , Papiloma/veterinaria , Papillomaviridae/aislamiento & purificación , Animales , Bovinos , China , Industria Lechera , Femenino , Glándulas Mamarias Animales/patología , Glándulas Mamarias Animales/virología , Epidemiología Molecular , Papiloma/epidemiología , Papiloma/virología , Papillomaviridae/genética , Infecciones por Papillomavirus/veterinaria , Reacción en Cadena de la Polimerasa/veterinaria
15.
Am J Otolaryngol ; 40(3): 368-371, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30799210

RESUMEN

PURPOSE: Laryngeal papillomatosis is the most common benign tumor of the larynx of children. It is characterized by the development of exophytic proliferative lesions in the mucosa of the airways. Human papillomavirus (HPV) has been recognized as a causal agent among which HPV types 6 and 11 are the most frequently implicated. This disease affects the vocal cords and other important functions of the child. The difficulty of treatment is related to the high recurrence of papilloma growth after surgical removal. The objective of this study was to describe the implication of HPV6 and HPV11 in cases of laryngeal papillomatosis histologically confirmed in Ouagadougou. MATERIALS AND METHODS: This was a descriptive cross-sectional study based on histologically diagnosed archival tissue; obtained in the last ten years (2007 to 2017) in the anatomy and cyto-pathology laboratories in Burkina Faso. These fixed and paraffin-embedded tissues were deparaffinized with xylene before HPV DNA extraction; then HPV6 and HPV 11 were identified by real-time multiplex PCR. RESULTS: The prevalence of low-risk HPV infection (HPV-LR) was 54.84% in histologically confirmed laryngeal papillomatosis in Ouagadougou. Among the HPV-LR positive samples, HPV6 and HPV11 genotype prevalence's were respectively 41.17% and 35.3% while the HPV6 / HPV11 co-infection was 23.53%. CONCLUSIONS: The results show the implication of HPV6 and HPV11 in laryngeal papillomatosis in Burkina Faso with a high prevalence.


Asunto(s)
Papillomavirus Humano 11/aislamiento & purificación , Papillomavirus Humano 11/patogenicidad , Papillomavirus Humano 6/aislamiento & purificación , Papillomavirus Humano 6/patogenicidad , Neoplasias Laríngeas/virología , Papiloma/virología , Adolescente , Adulto , Anciano , Burkina Faso/epidemiología , Niño , Preescolar , Coinfección/epidemiología , Coinfección/virología , Estudios Transversales , Genotipo , Papillomavirus Humano 11/genética , Papillomavirus Humano 6/genética , Humanos , Lactante , Neoplasias Laríngeas/epidemiología , Persona de Mediana Edad , Papiloma/epidemiología , Infecciones por Papillomavirus/epidemiología , Infecciones por Papillomavirus/virología , Reacción en Cadena de la Polimerasa , Prevalencia , Infecciones del Sistema Respiratorio/epidemiología , Infecciones del Sistema Respiratorio/virología , Riesgo , Adulto Joven
16.
Commun Biol ; 2: 54, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30775456

RESUMEN

Our recent Communications Biology research article revealed the genomic drivers and therapeutic vulnerabilities of sea turtle fibropapillomatosis tumors. Fibropapillomatosis is a debilitating tumorous disease afflicting populations of green sea turtles globally. While a virus is involved in the development of this disease, it is increasingly understood that the key trigger is linked to anthropogenic disturbances of the environment. The specific environmental co-trigger(s) has yet to be functionally confirmed. Here we outline the next steps required to advance our understanding of this enigmatic disease, to enable us to more effectively clinically combat it and to ultimately tackle its environmental co-trigger to halt and hopefully reverse the spread of fibropapillomatosis.


Asunto(s)
Enfermedades de los Animales/epidemiología , Fibrosis/veterinaria , Papiloma/veterinaria , Neoplasias Cutáneas/veterinaria , Infecciones Tumorales por Virus/veterinaria , Tortugas/virología , Alphaherpesvirinae/patogenicidad , Enfermedades de los Animales/patología , Enfermedades de los Animales/virología , Animales , Conservación de los Recursos Naturales , Fibrosis/epidemiología , Fibrosis/patología , Fibrosis/virología , Humanos , Oncología Médica/métodos , Océanos y Mares , Papiloma/epidemiología , Papiloma/patología , Papiloma/virología , Medicina de Precisión/métodos , Neoplasias Cutáneas/epidemiología , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/virología , Infecciones Tumorales por Virus/epidemiología , Infecciones Tumorales por Virus/patología , Infecciones Tumorales por Virus/virología
17.
Head Neck ; 41(5): 1412-1417, 2019 05.
Artículo en Inglés | MEDLINE | ID: mdl-30623508

RESUMEN

BACKGROUND: Laryngeal papillomatosis (LP) is a disease that presents in both juvenile (JLP) and adult patients (ALP). This study correlated papillomatosis characteristics with the Derkay score. METHODS: Retrospective data and biopsies of 36 patients with JLP and 56 with ALP were collected and separated into groups according to their scores. RESULTS: The mean of the Derkay score, in the JLP group was 10.97 and in Group ALP was 8.26. The JLP group presented a more aggressive result than in the adult group (P = .02). In the JLP group, the respiratory difficulty (P = .01) and tracheostomy were correlated to a higher Derkay score (P < .05). Microscopically, the JLP samples presented a higher incidence of atypical mitosis and mitosis above the basal cells layer of the epithelium (P < .05) and these characteristics were correlated with a higher Derkay index (P = .03). CONCLUSION: Findings suggest that ALP and JLP can present different clinical courses and histopathological features. There was a higher degree of LP severity in JLP.


Asunto(s)
Transformación Celular Neoplásica/patología , Progresión de la Enfermedad , Neoplasias Laríngeas/patología , Papiloma/patología , Adolescente , Factores de Edad , Biopsia con Aguja , Brasil/epidemiología , Niño , Preescolar , Bases de Datos Factuales , Femenino , Guatemala/epidemiología , Humanos , Inmunohistoquímica , Internacionalidad , Neoplasias Laríngeas/epidemiología , Masculino , Papiloma/epidemiología , Prevalencia , Pronóstico , Enfermedades Raras , Estudios Retrospectivos , Medición de Riesgo , Factores Sexuales , Estadísticas no Paramétricas
18.
Artículo en Inglés, Español | MEDLINE | ID: mdl-30497661

RESUMEN

INTRODUCTION AND OBJECTIVE: Oral benign neoplasms (OBNs) exhibit some features that can guide the professionals to the correct diagnosis and best treatment. Through retrospective studies, medical records can be reviewed to better describe a given population and, furthermore, help clinicians in routine practice. In this context, the objective of this paper was to analyze the cases of OBNs of an oral pathology referral department, from 2003 to 2017, in order to better understand their epidemiological and clinicopathological characteristics. METHODS: A total of 8355 histopathological reports were analyzed. Lesions diagnosed as OBNs were selected and the following variables were recorded: gender, age, histological type of the lesion, anatomical location, rate and pattern of growth, type of base, color, symptomatology and diagnostic hypotheses on clinical examination. RESULTS: OBNs represented 9.4% of all lesions diagnosed. The most frequent histopathological types were fibroma (39.9%), papilloma (22%), fibroblastoma (13.1%), lipoma (10.2%) and hemangioma (6.1%). Overall, most cases affected females (n=518; 65.6%) and in the fifth decade of life (n=148; 18.7%). The oral mucosa was the most common site (n=265; 33.5%). The most common features of each OBN were also highlighted. CONCLUSION: The most common OBNs were fibroma, papilloma, fibroblastoma, lipoma and hemangioma. Overall, the OBN presented common clinical features; however, in particular cases, there are some characteristics that can lead the professionals to the correct diagnosis. Nevertheless, in general, histopathological analysis must be performed to confirm diagnosis. Intraosseous tumors and large lesions may require imaging tests to help diagnosis.


Asunto(s)
Neoplasias de la Boca/patología , Adolescente , Adulto , Distribución por Edad , Anciano , Anciano de 80 o más Años , Brasil/epidemiología , Niño , Preescolar , Femenino , Fibroma/epidemiología , Fibroma/patología , Fibrosarcoma/epidemiología , Fibrosarcoma/patología , Hemangioma/epidemiología , Hemangioma/patología , Humanos , Lactante , Recién Nacido , Lipoma/epidemiología , Lipoma/patología , Masculino , Persona de Mediana Edad , Mucosa Bucal/patología , Neoplasias de la Boca/epidemiología , Papiloma/epidemiología , Papiloma/patología , Estudios Retrospectivos , Distribución por Sexo , Factores de Tiempo , Adulto Joven
19.
Vet Ophthalmol ; 22(3): 256-264, 2019 May.
Artículo en Inglés | MEDLINE | ID: mdl-30052302

RESUMEN

PURPOSE: To evaluate the recurrence frequency and the time to recurrence of canine palpebral masses treated with debulking and cryotherapy. METHODS: Medical records of dogs that underwent debulking and cryotherapy for palpebral masses from December 2010 to November 2015 at the University of Minnesota's Veterinary Medical Center were reviewed. A telephone survey with owners was used to determine recurrence and time to recurrence. RESULTS: Forty-six masses (31 dogs) were included in this retrospective study. Included palpebral masses were as follows: adenomas 17/46 (37%), epitheliomas 8/46 (17.4%), papillomas 6/46 (13%), inflammatory masses 6/46 (13%), mixed adenoma-papillomas 6/46 (13%), mixed epithelioma-papillomas 2/46 (4.4%), and a melanocytoma 1/46 (2.2%). Of the seven masses that were noted to recur (7/46, 15.2%), three were mixed adenoma-papillomas (three of six adenoma-papillomas, 50%), two were epitheliomas (two of eight epitheliomas, 25%), one was a papilloma (one of six papillomas, 16.7%), and one was a melanocytoma (one of one melanocytoma, 100%). Average recurrence time was 367.9 days [range: 30-904 days]. A significant association between tumor type and tumor recurrence was found (P = .009). Adenomas were significantly less likely to recur (P = .017), and mixed adenoma-papillomas were significantly more likely to recur (P = .001). CONCLUSIONS: Debulking and cryotherapy is an effective method of treatment for eyelid masses in dogs with a low study recurrence rate of 15.2% and average recurrence time of 367.9 days. Results also suggest that mixed adenoma-papilloma masses have a significantly higher recurrence rate than other eyelid masses, whereas adenomas had no recurrence in our study population.


Asunto(s)
Adenoma/veterinaria , Conjuntiva , Enfermedades de los Perros/epidemiología , Neoplasias del Ojo/veterinaria , Recurrencia Local de Neoplasia/veterinaria , Papiloma/veterinaria , Adenoma/epidemiología , Adenoma/cirugía , Animales , Crioterapia/veterinaria , Procedimientos Quirúrgicos de Citorreducción/veterinaria , Enfermedades de los Perros/diagnóstico por imagen , Enfermedades de los Perros/cirugía , Perros , Neoplasias del Ojo/epidemiología , Neoplasias del Ojo/cirugía , Femenino , Masculino , Minnesota/epidemiología , Recurrencia Local de Neoplasia/epidemiología , Recurrencia Local de Neoplasia/cirugía , Papiloma/epidemiología , Papiloma/cirugía , Complicaciones Posoperatorias/veterinaria , Registros/veterinaria , Estudios Retrospectivos , Resultado del Tratamiento
20.
Pan Afr Med J ; 30: 209, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30574228

RESUMEN

INTRODUCTION: Although Laryngeal papillomatosis is a rare disease and can be conventionally managed through surgical excision as well as adjuvant therapy yet Laryngeal papillomatosis has high tendency to recur raising its prevalence in the community, airway involvement warrants dangerous complications requiring emergency tracheostomy, especially if clinical course is poorly understood and misdiagnosis is common. The study aims to determine the prevalence, clinical features, risk factors and recurrence of Laryngeal Papillomatosis among patients attending ENT department at KCMC from 2005 to 2015. METHODS: This was a 10 year experience/ Descriptive hospital based cross-sectional study conducted based on patients' medical record at KCMC. Information was recorded into data collection sheets, entered and analyzed through SPSS version 20, summarized and presented in tables and charts, proportions and percentage used to compare groups. RESULTS: 51 patients were identified over the 10 years study period corresponding to a prevalence of 0.09%. 26 were males and 25 females, ages ranging from 1 to 67 years. The median age of onset was 6 years. Children less than 5 years accounted for 19 (37.3%) and 58.8% had repeated surgeries. Clinical presentation ranged from hoarseness in 43 (84.3%) patients to weight loss 3 (5.9%) and 96.1% showed complete or partial presence of the clinical triad of risk factors. CONCLUSION: Laryngeal papillomatosis is a rare disease that carries severe morbidity due to its highly recurring nature. It is primarily a paediatric disease, generally affecting more males; its clinical features highly resemble other airway obstructive diseases and therefore a careful thorough clinical evaluation is required in order to correctly diagnose Laryngeal papillomatosis.


Asunto(s)
Ronquera/etiología , Neoplasias Laríngeas/epidemiología , Papiloma/epidemiología , Pérdida de Peso , Adolescente , Adulto , Anciano , Niño , Preescolar , Estudios Transversales , Femenino , Humanos , Lactante , Pacientes Internos , Neoplasias Laríngeas/diagnóstico , Neoplasias Laríngeas/etiología , Masculino , Persona de Mediana Edad , Papiloma/diagnóstico , Papiloma/etiología , Prevalencia , Recurrencia , Factores de Riesgo , Tanzanía , Centros de Atención Terciaria , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...